Jump to content

Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Use of new oral anticoagulants in antiphospholipid syndrome.

antiphospholipid syndrome

  • Please log in to reply
No replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,616 posts
  • Location:West Sussex

Posted 16 July 2013 - 10:05 PM

Use of new oral anticoagulants in antiphospholipid syndrome.


The use of warfarin is problematic, particularly in patients with antiphospholipid syndrome (APS), where prospective clinical studies of new oral anticoagulants (NOAC) are the way forward. Pub Med Curr Rheumatol Rep, 2013 Jun;15(6):331. (Also see: Antiphospholipid Syndrome)


This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)

Also tagged with one or more of these keywords: antiphospholipid syndrome